Does GABAPENTIN ENACARBIL Cause Pulmonary embolism? 14 Reports in FDA Database

Q: Does GABAPENTIN ENACARBIL cause Pulmonary embolism?

14 reports of Pulmonary embolism have been filed with the FDA for GABAPENTIN ENACARBIL, representing 0.8% of all GABAPENTIN ENACARBIL adverse event reports.

Q: How dangerous is Pulmonary embolism from GABAPENTIN ENACARBIL?

Of 14 reports, 12 (85.7%) resulted in death and 13 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Pulmonary embolism have been filed in association with GABAPENTIN ENACARBIL (Horizant). This represents 0.8% of all adverse event reports for GABAPENTIN ENACARBIL.

Reports of Pulmonary embolism with GABAPENTIN ENACARBIL

0.8%

of all GABAPENTIN ENACARBIL reports

Deaths

Hospitalizations

How Dangerous Is Pulmonary embolism From GABAPENTIN ENACARBIL?

Of the 14 reports, 12 (85.7%) resulted in death, 13 (92.9%) required hospitalization, and 11 (78.6%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN ENACARBIL. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN ENACARBIL Cause?

Toxicity to various agents (592) Completed suicide (276) Off label use (158) Drug abuse (136) Drug ineffective (122) Cardio-respiratory arrest (109)<